Agilum has supplied NYU Langone Health and more than 45 other NY health systems – 21% percent of all hospitals in New York state – with the real-world data and analytics methodologies to track, analyze, and predict drug utilization data in real-time during the course of the COVID-19 crisis. This information is invaluable for health systems, pharmaceutical executives, and other stakeholders looking to manage the drug supply chain and avoid shortages during public health emergencies and during day-to-day operations.
“The data presented here show how rapid and extensive the impact on hospitals and drug supplies could be,” study authors wrote. “The data and observations can support clinicians, health-system leaders, public health officials, manufacturers, wholesalers, and state and federal policymakers in data analysis to enhance medication production and forecasting of demand and supply for current or future pandemics.”
The results of NYU Langone’s analysis, which identified drug utilization trends for seven medications used to treat patients with suspected or confirmed COVID-19 at 47 New York hospitals, were published in the July issue of the American Journal of Health System Pharmacy.
Download the peer-reviewed July 2020 American Journal of Health-System Pharmacy article today.
Simply fill out the form below for full access to “Medication utilization in patients in New York hospitals during the COVID-19 pandemic.”